Perrigo’s Albuterol Advantage Blunted By Recall
ProAir Rival Sees ‘Clogging’ Complaints; Cipla And Lupin Also Have Generic Albuterol
Executive Summary
After a high-profile launch early this year, first-mover Perrigo has recalled its albuterol sulfate aerosol in the US following complaints of inhalers failing to dispense due to “clogging.” The firm has revealed the expected financial impact of the move as well as commenting on how long it expects the product to be off the market, during which albuterol rivals Cipla and Lupin could benefit.